Latest Breaking News On - Vista pharmaceuticals - Page 8 : comparemela.com

KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants

KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoNew yorkBryan bakerStefan klotterJarrod aldomEquity syndicate prospectus departmentKalvista pharmaceuticals incCantor fitzgerald coDrug administrationNeedham companyExchange commissionLeerink partnersNicolaus company incorporatedCorporate communicationsSyndicate department

KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants

KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mashonaland eastUnited kingdomUnited statesNew yorkSan franciscoBryan bakerJarrod aldomEquity syndicate prospectus departmentExchange commissionLeerink partnersSyndicate departmentKalvista pharmaceuticals incDrug administrationNicolaus company incorporatedCantor fitzgerald coNeedham company

KalVista Pharmaceuticals (NASDAQ:KALV) Reaches New 52-Week High on Analyst Upgrade

KalVista Pharmaceuticals (NASDAQ:KALV) Reaches New 52-Week High on Analyst Upgrade
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesEdwardp feenerHedge funds weigh in on kalvista pharmaceuticalsKalvista pharmaceuticals stockKalvista pharmaceuticals incKalvista pharmaceuticalsSecurities exchange commissionRoyal bankNeedham companyTower research capitalInsider transactions at kalvista pharmaceuticalsAmerican international group incNews ratings for kalvista pharmaceuticals dailyNorthern trust corpGet free reportVista pharmaceuticals

Two Biotech/pharma stocks to watch - STTK, KALV

Two Biotech/pharma stocks to watch - STTK, KALV
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesKalvista pharmaAmerican academy of allergy asthmaKalvista pharmaceuticalsBlue capsulesModern pharmaceuticalCapsule manufacturingClose up shotMedical drug productionShattuck labsLabs strikes dealOno pharmaOno pharmaceuticalAvista pharmaVista pharmaceuticalsHereditary angioedema

KalVista: Positive Results From Phase 3 Trial Pave The Way For Commercialization

KalVista: Positive Results From Phase 3 Trial Pave The Way For Commercialization
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesGaleanu mihaiNeues jahrKalvista pharmaTherapy company presentationKalvista pharmaceuticals financialBusiness of kalvista pharmaceuticalsKalvista pharmaceuticalsKalvista pharmaceuticals authorTransition to bea commercial companyVista pharmaceuticalsProject salamanderSuccessful launchSignificant portionWith opportunities